S100A4 Human

S100 Calcium-Binding Protein A4 Human Recombinant
Cat. No.
BT30025
Source
Escherichia Coli.
Synonyms
Protein S100-A4, S100 calcium-binding protein A4, Metastasin, Protein Mts1, Placental calcium-binding protein, Calvasculin, S100A4, CAPL, MTS1, 42A, 18A2, FSP1, P9KA, PEL98.
Appearance
Sterile Filtered clear solution.
Purity
Greater than 95.0% as determined by SDS-PAGE.
Usage
Prospec's products are furnished for LABORATORY RESEARCH USE ONLY. The product may not be used as drugs, agricultural or pesticidal products, food additives or household chemicals.
Shipped with Ice Packs
In Stock

Description

S100A4 Human Recombinant produced in E.coli is a single, non-glycosylated polypeptide chain containing 121 amino acids (1-101) and having a molecular mass of 13.8 kDa.
The S100A4 is fused to a 20 amino acid His-Tag at N-terminus and purified by proprietary chromatographic techniques.

Product Specs

Introduction
S100A4, a member of the S100 protein family, possesses two EF-hand calcium-binding domains. Its overexpression is observed ubiquitously, and it is localized within the cytoplasm and/or nucleus. This protein plays a role in cellular motility, invasion, and the polymerization of tubulin. Notably, alterations in the S100A4 gene, including chromosomal rearrangements and expression changes, have been linked to tumor metastasis.
Description
Recombinant human S100A4, produced in E. coli, is a single, non-glycosylated polypeptide chain consisting of 121 amino acids (residues 1-101) with a molecular weight of 13.8 kDa. This protein is engineered with a 20 amino acid His-Tag fused to its N-terminus and is purified using proprietary chromatographic methods.
Physical Appearance
A clear solution that has undergone sterile filtration.
Formulation
S100A4 protein is supplied in a buffer containing 20mM Tris-HCl at a pH of 8 and 10% glycerol.
Stability
For short-term storage (2-4 weeks), the product can be stored at 4°C. For extended periods, storage at -20°C in a frozen state is recommended. The addition of a carrier protein (0.1% HSA or BSA) is advisable for long-term storage. It is crucial to avoid repeated freeze-thaw cycles.
Purity
The purity of the protein is determined to be greater than 95.0% based on SDS-PAGE analysis.
Synonyms
Protein S100-A4, S100 calcium-binding protein A4, Metastasin, Protein Mts1, Placental calcium-binding protein, Calvasculin, S100A4, CAPL, MTS1, 42A, 18A2, FSP1, P9KA, PEL98.
Source
Escherichia Coli.
Amino Acid Sequence
MGSSHHHHHH SSGLVPRGSH MACPLEKALD VMVSTFHKYS GKEGDKFKLN KSELKELLTR ELPSFLGKRT DEAAFQKLMS NLDSNRDNEVDFQEYCVFLS CIAMMCNEFF EGFPDKQPRK K.

Product Science Overview

Introduction

S100 Calcium-Binding Protein A4 (S100A4), also known as metastasin, is a member of the S100 family of proteins. These proteins are characterized by their ability to bind calcium ions through EF-hand motifs, which are helix-loop-helix structural domains . S100A4 is encoded by the S100A4 gene located on chromosome 1q21 in humans .

Structure and Function

S100A4 is a small protein consisting of 101 amino acids . It contains two EF-hand calcium-binding motifs, which are crucial for its function. The protein is localized in the cytoplasm and/or nucleus of various cell types and is involved in several cellular processes, including cell motility, invasion, and tubulin polymerization .

Biological Roles

S100A4 plays a significant role in the regulation of the cell cycle, differentiation, and apoptosis. It is also involved in the epithelial to mesenchymal transition (EMT), a process critical for cancer metastasis . The protein interacts with non-muscle myosin heavy chain IIA (NMMHC IIA), enhancing cell motility and invasiveness .

Clinical Significance

The expression of S100A4 is often upregulated in various cancers, including breast, colorectal, and pancreatic cancers . Its overexpression is associated with poor prognosis and increased metastatic potential. S100A4 has been shown to interact with other proteins, such as S100A1, and is implicated in tumor progression and metastasis .

Therapeutic Potential

Given its role in cancer progression, S100A4 is considered a potential therapeutic target. Inhibiting its expression or function could potentially reduce tumor invasiveness and metastasis . Research is ongoing to develop specific inhibitors that can target S100A4 and its interactions with other proteins.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2024 Thebiotek. All Rights Reserved.